相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Salinomycin encapsulated nanoparticles as a targeting vehicle for glioblastoma cells
R. Seda Tigli Aydin et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2016)
Apoptotic effects of salinomycin on human ovarian cancer cell line (OVCAR-3)
Fuat Kaplan et al.
TUMOR BIOLOGY (2016)
Salinomycin suppresses TGF-β1-induced epithelial-to-mesenchymal transition in MCF-7 human breast cancer cells
Chunying Zhang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel
Eameema Muntimadugu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Salinomycin efficiency assessment in non-tumor (HB4a) and tumor (MCF-7) human breast cells
Andressa Megumi Niwa et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)
Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis
Tao Li et al.
ONCOTARGET (2016)
Anticancer Activity of Polyether Ionophore-Salinomycin
Michal Antoszczak et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin
Masaya Kai et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling
Ying Lu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients
Miao He et al.
CLINICAL SCIENCE (2015)
Polymeric Micelles of PEG-PLA Copolymer as a Carrier for Salinomycin Against Gemcitabine-Resistant Pancreatic Cancer
Zahra Daman et al.
PHARMACEUTICAL RESEARCH (2015)
Effect of salinomycin on metastasis and invasion of bladder cancer cell line T24
Hu Qu et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2015)
Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation
Yue Zhou et al.
ONCOTARGET (2015)
Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death
Jaganmohan R. Jangamreddy et al.
ONCOTARGET (2015)
Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells
Hyunsook An et al.
PLOS ONE (2015)
Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo
Danxin Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma
E. Sanchez-Tillo et al.
CELL DEATH AND DIFFERENTIATION (2014)
PTEN Loss-Mediated Akt Activation Increases the Properties of Cancer Stem-Like Cell Populations in Prostate Cancer
Ran-Ju Kim et al.
ONCOLOGY (2014)
Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
Sara Haggblad Sahlberg et al.
PLOS ONE (2014)
Roles of Wnt/beta-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment
J. Mao et al.
CELL DEATH & DISEASE (2014)
Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells
Tianliang Li et al.
AUTOPHAGY (2013)
Salinomycin induces apoptosis and senescence in breast cancer: Upregulation of p21, downregulation of survivin and histone H3 and H4 hyperacetylation
Yusra Al Dhaheri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas
Sven-T Liffers et al.
BMC CANCER (2013)
Salinomycin: A Novel Anti-Cancer Agent with Known Anti-Coccidial Activities
Shuang Zhou et al.
CURRENT MEDICINAL CHEMISTRY (2013)
The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells
Soshi Kusunoki et al.
GYNECOLOGIC ONCOLOGY (2013)
Low Amount of Salinomycin Greatly Increases Akt Activation, but Reduces Activated p70S6K Levels
Ju-Hwa Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Herceptin-decorated Salinomycin-loaded nanoparticles for breast tumor targeting
R. Seda Tigli Aydin
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2013)
Inhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1
Kholoud Arafat et al.
PLOS ONE (2013)
Dose-Dependent Adverse Effects of Salinomycin on Male Reproductive Organs and Fertility in Mice
Olajumoke Omolara Ojo et al.
PLOS ONE (2013)
Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species
Jin Zhou et al.
TOXICOLOGY LETTERS (2013)
Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2
K. H. Koo et al.
CELL DEATH & DISEASE (2013)
What makes cancer stem cell markers different?
Uwe Karsten et al.
SPRINGERPLUS (2013)
Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance
Edita Aksamitiene et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles
Yang Zhang et al.
BIOMATERIALS (2012)
Antiproliferative activity of salinomycin and its derivatives
Adam Huczynski et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro
Thorsten Lieke et al.
BMC CANCER (2012)
Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt
Selena Z. Kuo et al.
BMC CANCER (2012)
Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress
K. Ketola et al.
BRITISH JOURNAL OF CANCER (2012)
Epigenetic modifications in cancer
R. Kanwal et al.
CLINICAL GENETICS (2012)
Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells
Prajakta S. Oak et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Lower Salinomycin Concentration Increases Apoptotic Detachment in High-Density Cancer Cells
Ju-Hwa Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest
Won Ki Kim et al.
INVESTIGATIONAL NEW DRUGS (2012)
Salinomycin as a Drug for Targeting Human Cancer Stem Cells
Cord Naujokat et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species
Berlinda Verdoodt et al.
PLOS ONE (2012)
Establishment and Characterization of a Highly Tumourigenic and Cancer Stem Cell Enriched Pancreatic Cancer Cell Line as a Well Defined Model System
Johannes Fredebohm et al.
PLOS ONE (2012)
Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In Vivo
Fan Wang et al.
PLOS ONE (2012)
Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein
Ju-Hwa Kim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Salinomycin inhibits osteosarcoma by targeting its tumor stem cells
Qing-Lian Tang et al.
CANCER LETTERS (2011)
Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells
Guan-Nan Zhang et al.
CANCER LETTERS (2011)
Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas
Devraj Basu et al.
CELL CYCLE (2011)
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis
Sharanjot Saini et al.
CLINICAL CANCER RESEARCH (2011)
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
Desheng Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Salinomycin induces calpain and cytochrome c-mediated neuronal cell death
W. Boehmerle et al.
CELL DEATH & DISEASE (2011)
miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines
Jon C. Henry et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells
Dominik Fuchs et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor
Roberta Riccioni et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc
Feng-Hou Gao et al.
BMC CANCER (2010)
β-Catenin Mediates the Establishment and Drug Resistance of MLL Leukemic Stem Cells
Jenny Yeung et al.
CANCER CELL (2010)
MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
Francesca Fornari et al.
CANCER RESEARCH (2010)
Kitlow Stem Cells Cause Resistance to Kit/Platelet-Derived Growth Factor α Inhibitors in Murine Gastrointestinal Stromal Tumors
Michael R. Bardsley et al.
GASTROENTEROLOGY (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer
Chang Gong et al.
PLOS ONE (2010)
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells
Dominik Fuchs et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells
Yu-Zhuo Pan et al.
MOLECULAR PHARMACOLOGY (2009)
Comparative gene expression analysis of a chronic myelogenous leukemia c-ell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors
Fei Bao et al.
LEUKEMIA RESEARCH (2007)
Salinomycin toxicosis in horses
Monica Aleman et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2007)
The prognostic role of a gene signature from tumorigenic breast-cancer cells.
Rui Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Nuclear factor-κB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer
Hiroshi Nakashima et al.
CANCER RESEARCH (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
LA Doyle et al.
ONCOGENE (2003)
Central roles of α5β1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies
SE Francis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
The Hedgehog and Wnt signaling pathways in cancer
J Taipale et al.
NATURE (2001)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
